Ultime notizie per Hyperfine (NASDAQ:HYPR) Azioni

Hyperfine

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.

Hyperfine Inc

HydrogenPro ASA

HYPROP INVESTMENTS by Hyprop Investments Ltd.

Hyprr

U.S.-listed Chinese stocks Alibaba Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>),&nbsp;Baidu, Inc. (NASDAQ: BIDU),&nbsp;JD.Com, Inc. (NASDAQ: JD),&nbsp;and&nbsp;PDD Holdings Inc. (NASDAQ: PDD)&nbsp;are trading lower on Thursday as President&nbsp;Donald Trump confirmed a <a target="_blank" href="https://www.benzinga.com/news/25/06/45882971/wall-street-eyes-record-highs-as-trump-seals-china-deal-soft-inflation-eases-tariff-jitters" rel="noreferrer noopener">China trade deal</a> after two days of negotiations in London.
It is worth noting that the tariffs are in place despite fresh inflation data coming in softer&nbsp;than expected for May.
The U.S. will continue applying 55% tariffs on selected Chinese imports, while China will impose a 10% tariff rate on U.S. goods.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/large-cap/25/06/45729089/china-stocks-get-boost-as-ubs-hsbc-cite-stimulus-hopes-tariff-truce-cheap-valuations" rel="noreferrer noopener">China Stocks Get Boost As UBS, HSBC Cite Stimulus Hopes, Tariff Truce, Low Valuations</a>
Chinese EV stocks, including&nbsp;Nio Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>), Li Auto Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>), and XPeng Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>), are also trading lower.
U.S. and Chinese officials met in London on Monday for trade talks, which, according to reports, likely focused on rare earth minerals.
<a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/06/45841817/us-listed-chinese-stocks-gain-as-us-china-trade-talks-spark-optimism" rel="noreferrer noopener">The meeting came</a> after Trump and Chinese President Xi Jinping discussed trade issues on the phone&nbsp;last week.
China has reportedly&nbsp;granted temporary approvals&nbsp;for the export of rare earths, while jetliner&nbsp;Boeing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) has&nbsp;begun commercial jet deliveries&nbsp;in China.
Rare earth elements play significant roles, from smartphones to electric vehicles to fighter jets. The U.S. depends on China for ~70% of imports of rare earth elements, signaling U.S. supply chain risks, SCMP&nbsp;<a target="_blank" href="https://www.scmp.com/economy/global-economy/article/3313697/ahead-us-china-talks-chinas-rare-earth-trade-data-may-shows-leverage-action" rel="noreferrer noopener">reported</a> on Monday, citing analyst estimates.
<h2 class="wp-block-heading">PDD Holding Stock Prediction For 2025</h2>
Equity research can be a valuable source of information for learning about a company's fundamentals. Analysts create financial models based on the fundamentals and expected future earnings of a company to arrive at a price target and recommendation for the stock.
Shares of PDD Holdings have an average 1-year price target of $132.7, representing an expected upside of 28.64%.
Because of differences in assumptions, analysts can arrive at very different price targets and recommendations. No analysts have bearish recommendations on PDD Holdings, while 5 analysts have bullish ratings. The street high price target from Citigroup is $165.0, while the street low from JP Morgan is $105.0.
Price Action: BABA shares are trading lower by 2.67%, BIDU by 0.25%, XPEV by 2.55% and NIO by 1.60%, PDD down 1.60% in the premarket session at the last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45840001/apples-wwdc-analyst-sees-ai-unveil-siri-revamp-and-alibaba-deal-as-catalyst-for-iphone-upgrade" target="_blank" rel="noreferrer noopener">Apple&#8217;s WWDC: Analyst Sees AI Unveil, Siri Revamp And Alibaba Deal As Catalyst For iPhone Upgrade</a></li>
</ul>
Photo via Shutterstock

News

Movers

Media

BABA

XPEV

US Listed Chinese Tech And EV Stocks Slide As Trump Confirms China Trade Deal

Needham analyst Gil Blum reiterates Fate Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATE#NASDAQ">FATE</a>) from Hold to Hold.

Reiteration

Analyst Ratings

FATE

Needham Reiterates Hold on Fate Therapeuticsto Hold

<a href="https://www.globenewswire.com/Tracker?data=63kUTdvgMrLIKQ-oU7LLmP3BAN0y5HH2Yk9j6PTCa3_2-z8ezKwLTP-HS5ernlQ3FitgnXapefoNhkKQD4eGP_R9aIB-E65xLs0UAs_VAW-XaQVP1jR_q5gQpdaieC8A">ReShape Lifesciences</a>&#xAE; (NASDAQ:<a href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>), the premier physician-led weight loss and metabolic health solutions company, today announced the signing of an exclusive U.S. distribution agreement with Recon Supply. Through this new strategic partnership, Recon Supply will distribute ReShape's cutting-edge portfolio, including the STIMEL-03 neuromuscular rehabilitation device, the next-generation Lap-Band&#xAE; 2.0 FLEX, and the full range of ReShape products, across the Veterans Administration (VA) and Department of Defense (DoD) healthcare systems. This collaboration will expand access to proven, life-changing treatments for more than 18 million U.S. veterans and active military personnel.

RSLS

ReShape Lifesciences Signs U.S. Distribution Agreement With Recon Supply To Distribute ReShape's Cutting-Edge Portfolio Across VA And DoD Healthcare Systems

Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) reported better-than-expected fourth-quarter financial results and issued <a href="https://www.benzinga.com/quote/ORCL/earnings">upbeat outlook commentary on Wednesday.</a>
The company reported fourth-quarter revenue of $15.9 billion, beating analyst estimates of $15.58 billion. The company reported fourth-quarter adjusted earnings of $1.70 per share, beating analyst estimates of $1.64 per share, according to Benzinga Pro.
"FY25 was a very good year — but we believe FY26 will be even better as our revenue growth rates will be dramatically higher," said Safra Catz, CEO of Oracle. "We expect our total cloud growth rate — applications plus infrastructure — will increase from 24% in FY25 to over 40% in FY26. Cloud Infrastructure growth rate is expected to increase from 50% in FY25 to over 70% in FY26. And RPO is likely to grow more than 100% in FY26."
Oracle's board declared a quarterly cash dividend of 50 cents per share, payable on July 24 to shareholders of record as of July 10.
Oracle's shares fell 0.6% to close at $176.38 on Wednesday.
These analysts made changes to their price targets on Oracle following earnings announcement.
<ul class="wp-block-list">
<li>Piper Sandler analyst Brent Bracelin maintained Oracle with a Neutral and raised the price target from $130 to $190.</li>
<li>WestPark Capital analyst Curtis Shauger maintained the stock with a Buy and boosted the price target from $195 to $246.</li>
</ul>
Considering buying ORCL stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/ORCL/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="584" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12082525/image-192-1024x584.png" alt="" class="wp-image-947574" style="width:712px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12082525/image-192-1024x584.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12082525/image-192-300x171.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12082525/image-192-768x438.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12082525/image-192.png 1092w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45882911/top-2-consumer-stocks-that-may-plunge-in-june">Top 2 Consumer Stocks That May Plunge In June</a> </li>
</ul>
Photo via Shutterstock

Earnings

Price Target

Pre-Market Outlook

Markets

Trading Ideas

ORCL

These Analysts Increase Their Forecasts On Oracle Following Upbeat Q4 Earnings

WIIM

NEHC

New Era Helium shares are trading higher after the company announced that its joint venture with Sharon AI, Texas Critical Data Centers, is in active discussions with enterprises to anchor its planned AI infrastructure buildout in Texas.

Maxim Group analyst Jack Vander Aarde upgrades Datavault AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DVLT#NASDAQ">DVLT</a>) from Hold to Buy and announces $3 price target.

Upgrades

DVLT

Maxim Group Upgrades Datavault AI to Buy, Announces $3 Price Target

Oxford Industries shares are trading lower after the company reported Q1 financial results and issued Q2 adjusted EPS guidance below estimates. Also, the company lowered its FY25 guidance.

HUB Cyber Security Ltd. (NASDAQ: HUBC) ("HUB" or the "Company"), a global leader in confidential computing and advanced secured data fabric technology, today announced that it is in full compliance with all applicable listing requirements of the Nasdaq Capital Market.
Nasdaq has formally confirmed that HUB satisfies both the minimum bid price and the market value of listed securities (MVLS) thresholds under Listing Rules 5550(a)(5) and 5550(b)(2), the "Bid Price" and "MVLS Rules," respectively. This milestone follows a period of strategic restructuring, improved financial execution, and strengthened corporate governance. Moreover, the Nasdaq Hearings Panel (the "Panel") has confirmed that HUB has met all exceptions in the Panel's decision in achieving compliance with the Nasdaq Bid Price and MVLS Rules listing standards.

HUBC

HUB Cyber Security Says It Is In Full Compliance With All Applicable Listing Requirements Of Nasdaq Capital Market

Chimera Investment Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>) announced Thursday it will acquire HomeXpress Mortgage Corp., a non-QM and non-agency loan originator with a nationwide footprint <a href="https://www.benzinga.com/pressreleases/25/06/b45900081/chimera-investment-corporation-nyse-cim-chimera-announces-definitive-agreement-to-acquire-homexpre">spanning 46 states and Washington, D.C</a>.
The deal, signed on June 11, includes a payment of $120 million in cash and 2,077,151 shares of Chimera stock. It will be executed through Chimera's taxable REIT subsidiary, Chimera Funding TRS.
The acquisition will expand Chimera's access to mortgage loan origination and strengthen its securitization and servicing operations, aligning with its long-term growth strategy. The transaction is expected to close in the fourth quarter of 2025.
Also Read: <a href="https://www.benzinga.com/real-estate/25/06/45831855/gen-z-turns-to-siblings-and-side-hustles-to-afford-homes-amid-soaring-prices">Gen Z Turns To Siblings And Side Hustles To Afford Homes Amid Soaring Prices</a>
Chimera anticipates the deal will be earnings-accretive beginning in 2026. HomeXpress has operated profitably since its founding in 2016, generating $47 million in pre-tax income in 2024. 
The company originated $2.5 billion in loans last year and projects $3.5 billion in volume for 2025, supported by its strong broker and correspondent partner network.
Following the acquisition, HomeXpress will continue as a wholly owned subsidiary, with CEO Kyle Walker and his senior leadership team staying on to lead the business.
Chimera also plans to leverage existing net operating losses to offset the acquisition premium. It will gain additional revenue streams through origination fees and gain-on-sale income, helping diversify its earnings base.
CIM held cash and cash equivalents of <a href="https://www.benzinga.com/pressreleases/25/05/b45280351/chimera-investment-corporation-reports-1st-quarter-2025-earnings" target="_blank" rel="noreferrer noopener">$253.349 million</a> as of March 31, 2025.
Other companies involved in the residential and mortgage sector include PennyMac Financial Services Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFSI#NYSE">PFSI</a>) and Rocket Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>).
Investors may also watch mortgage-focused ETFs, such as the iShares MBS ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBB#NASDAQ">MBB</a>) and the VanEck Mortgage REIT Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MORT#NYSE">MORT</a>).
Price Action: CIM shares are trading lower by 0.22% to $13.89 premarket at last check Thursday.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/commodities/25/06/45900930/gold-surpasses-euro-to-become-second-largest-reserve-asset-still-far-behind-dollar-ecb-says" target="_blank" rel="noreferrer noopener">Gold Surpasses Euro To Become Second-Largest Reserve Asset, Still Far Behind Dollar, ECB Says</a></li>
</ul>
Photo by Gumbariya via Shutterstock

MORT

PFSI

Chimera Expands Mortgage Reach With HomeXpress Acquisition

Yiren Digital shares are trading lower after the company reported a year-over-year decrease in Q1 EPS results.

Lake Street analyst Frank Takkinen assumes Beta Bionics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBNX#NASDAQ">BBNX</a>) with a Buy rating and announces Price Target of $30.

Initiation

BBNX

Lake Street Assumes Beta Bionics at Buy, Announces Price Target of $30

DFDV

DeFi Development shares are trading lower. The company announced it secured a $5 billion equity facility with RK Capital.

Needham analyst Bernie McTernan maintains Genius Sports (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GENI#NYSE">GENI</a>) with a Buy and maintains $13 price target.

GENI

Needham Maintains Buy on Genius Sports, Maintains $13 Price Target

Inuvo, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INUV#NYSE">INUV</a>), a leading provider of artificial intelligence-driven AdTech solutions, today announced that it was reaffirming its prior guidance that the Company was expecting revenue growth for the second quarter of not less than 25% on a year-over-year basis. The Company also completed a 1-for-10 reverse stock split of its outstanding common stock, as approved by shareholders at the Annual Meeting held on May 22, 2025.

Guidance

Stock Split

INUV

Inuvo Reaffirms Q2 Revenue Growth Guidance Of Not Less Than 25% YoY; Completes 1:10 Reverse Stock Split

CVGW

Calavo Growers shares are trading higher after the company announced it received a non-binding proposed to acquire shares at 32.00 per share.

<a href="https://www.benzinga.com/money/what-is-ethereum-etf">Spot Ethereum exchange-traded funds</a> recorded $240 million in net inflows on June 11, surpassing Bitcoin ETFs' $165 million and extending Ethereum's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) inflow streak to 18 consecutive days, according to Farside Investors.
This marks a significant shift in investor preference, driven by Ethereum's technical advancements and positive regulatory developments, contrasting with Bitcoin's struggle to break the $110,000 resistance level.
What Experts Are Saying: In a note sent to Benzinga, Alex Kuptsikevich, FxPro's chief market analyst, noted, "Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) fell below $108,000, once again encountering a sell-off after touching $110,000."
He attributed the crypto market's 1.6% capitalization drop to $3.39 trillion to pressures on risky assets from Middle East tensions, describing the sell-off as a temporary, technical setback. 
Despite this, he remains optimistic about cryptocurrencies, citing the dollar's proximity to multi-year lows as a bullish signal for the near term.
Ethereum's outperformance is fueled by a combination of factors, according to Dom Harz, Co-Founder of BOB. 
"The momentum reflects a meaningful shift in sentiment, fuelled by a combination of technical progress, market activity, and regulatory signals," He stated.
The Pectra upgrade, implemented in May, has enhanced Ethereum's scalability, while SEC Commissioner Paul Atkins' support for decentralized finance and <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45852973/circle-ipo-success-suggests-markets-open-to-new-listings-especially-from-crypto-businesses-says-spac-king-chamath-palihapitiya">Circle's successful IPO</a> have bolstered confidence.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45883099/cantor-fitzgerald-wall-street-companies-will-lower-crypto-lending-costs-salt-ceo-says">Cantor Fitzgerald, Wall Street Companies Will Lower Crypto Lending Costs, SALT CEO Says</a>
"These are exciting times for DeFi and for Ethereum's role in the industry's next chapter,&#8221; Harz added.
Przemysław Kral, CEO of zondacrypto, emphasized the role of regulation in driving ETF inflows, saying, "The rising inflows into crypto ETFs can be attributed to the increased regulation of the crypto industry, which attracts traditional financial institutions into the market." 
He dismissed concerns about ETFs undermining decentralization, noting, "ETFs are like licking the pages of a cookbook—they give you exposure but not access to the real asset." 
Kral argued that while inflows may distort market cycles, they enhance the crypto market's credibility, a key step toward maturity.
What&#8217;s Next: Ethereum ETFs' sustained inflows reflect growing institutional interest, with BlackRock's iShares Ethereum Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETHA#NASDAQ">ETHA</a>) leading the pack, as <a href="https://www.theblock.co/post/357880/spot-ethereum-etfs-pull-in-240-million-beating-bitcoin-etfs-164-million-daily-inflows?utm_source=rss&amp;utm_medium=rss">reported</a> by The Block.
In contrast, Bitcoin ETFs, led by BlackRock's iShares Bitcoin Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) with $131 million in inflows, faced challenges from market volatility and Bitcoin's failure to consolidate above $110,000. 
The divergence highlights Ethereum's appeal as investors anticipate further DeFi growth and potential staking opportunities, which could drive additional inflows in 2025.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45880505/public-company-bitcoin-holdings-are-a-megatrend-just-getting-started-says-bitwises-matt-hougan">Public Company Bitcoin Holdings Are A &#8216;Megatrend&#8217; Just Getting Started, Says Bitwise&#8217;s Matt Hougan</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

ETHA

IBIT

Ethereum ETFs Outpace Bitcoin ETFs With $240M Inflows On June 11

KARO

Karooooo shares are trading lower after the company announced the pricing of an $75 million underwritten public offering of 1.50 million ordinary shares held by CEO Isaias Jose Calisto at $50 per share.

Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) shares closed lower on Wednesday as investors continued to digest announcements from this week's <a href="https://www.benzinga.com/topic/wwdc">Worldwide Developers Conference.</a>
The much-anticipated event showcased updates across Apple's operating systems, including a new design language called "Liquid Glass," but left some analysts and investors underwhelmed by its advancements in artificial intelligence.
With the recent buzz around Apple, some investors may be eyeing potential gains from the company's dividends too. As of now, Apple offers an annual dividend yield of 0.52%, which is a quarterly dividend amount of 26 cents per share ($1.04 a year).
To figure out how to earn $500 monthly from Apple, we start with the yearly target of $6,000 ($500 x 12 months).
Next, we take this amount and divide it by Apple $1.04 dividend: $6,000 / 1.04 = 5,769 shares.
So, an investor would need to own approximately $1,146,762 worth of Apple, or 5,769 shares to generate a monthly dividend income of $500.
Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $1.04 = 1,154 shares, or $229,392 to generate a monthly dividend income of $100.
Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.
The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change.
For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60).
Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40).
Further, the dividend payment itself can also change over time, which can also impact the dividend yield. If a company increases its dividend payment, the dividend yield will increase even if the stock price remains the same. Similarly, if a company decreases its dividend payment, the dividend yield will decrease.
AAPL Price Action: Shares of Apple fell by 1.9% to close at $198.78 on Wednesday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45882911/top-2-consumer-stocks-that-may-plunge-in-june">Top 2 Consumer Stocks That May Plunge In June</a></li>
</ul>
Photo: Akhenaton Images/Shutterstock

Long Ideas

Dividends

AAPL

How To Earn $500 A Month From Apple Stock

IonQ Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NASDAQ">IONQ</a>) is solidifying its stronghold in the quantum computing space as a recent sector endorsement by Jensen Huang, partnership with Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), and the <a href="https://www.benzinga.com/m-a/25/06/45832398/ionq-buys-oxford-ionics-in-1-075-billion-deal-to-supercharge-quantum-tech">acquisition of Oxford Ionics</a> have drawn investor attention to the company.
What Happened: Its recent definitive agreement to acquire U.K.-based Oxford Ionics for $1.075 billion will &#8220;meaningfully accelerate IonQ&#8217;s technology roadmap,&#8221; said Needham.
This strategic move propels IonQ towards ambitious targets: a 256 physical qubit system by 2026, 10,000 physical qubits by 2027, and a staggering 2 million physical qubits by 2030, all while achieving increasingly higher logical accuracy.
Needham highlights that these targets will be achieved as IonQ leverages Oxford&#8217;s ion-trap technology and uses its own control software, networking stack, and manufacturing capabilities
Needham &amp; Company has reiterated its &#8220;Buy&#8221; rating on IonQ, maintaining a $50 price target in a note dated June 11.
This comes as Nvidia CEO Huang turned back on his <a href="https://www.benzinga.com/markets/equities/25/01/42867168/nvidias-jensen-huang-said-something-that-has-all-quantum-computing-stocks-tumbling-qubt-and-rgti-down-13-ionq-down-11">January statement</a>, and said quantum computing is reaching a pivotal &#8220;<a href="https://www.benzinga.com/markets/tech/25/06/45885805/nvidias-jensen-huang-sparks-quantum-stock-frenzy">inflection point</a>,&#8221; during his keynote speech at a company event being held jointly with the VivaTech 2025 conference in Paris. 
He also added that quantum computing is poised to &#8220;solve some interesting problems&#8221; globally in the coming years.
See Also: <a href="https://www.benzinga.com/markets/macro-economic-events/25/06/45900891/mark-cuban-backs-ro-khannas-12-trillion-progressive-deficit-reduction-plan-targetin">Mark Cuban Backs Ro Khanna&#8217;s $12 Trillion &#8216;Progressive Deficit Reduction Plan,&#8217; Targeting Medicare Fraud And Military Spending</a>
Why It Matters: The path to practical quantum advantage increasingly involves hybrid quantum-classical computing, and IonQ has demonstrated its leadership in this domain after a partnership with Nvidia.
It is already working on <a href="https://ionq.com/news/ionq-to-advance-hybrid-quantum-computing-with-new-chemistry-application-and">hybrid computing</a>, leveraging the NVIDIA CUDA-Q platform alongside its IonQ Forte hardware. This collaboration illustrates the seamless integration of quantum processing units (QPUs) with Nvidia&#8217;s accelerated computing capabilities. 
Further solidifying this synergy, IonQ, in partnership with AstraZeneca PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>), Amazon.com Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Amazon Web Services (AWS), and Nvidia, recently achieved a remarkable 20 times speedup in a <a href="https://ionq.com/news/ionq-speeds-quantum-accelerated-drug-development-application-with#:~:text=COLLEGE%20PARK%2C%20MD%20%2D%20June%209,quantum%2Daccelerated%20computational%20chemistry%20workflow">critical drug development workflow</a>. 
Price Action: Shares of IonQ ended 0.10% lower on Wednesday, and they were down 1.81% in premarket on Friday. It has fallen 7.89% on a year-to-date basis and surged 399.37% over a year.
About seven analysts covering IonQ are <a href="https://www.benzinga.com/quote/IONQ/analyst-ratings">tracked by Benzinga</a>. They have a consensus target price of $40 apiece, with a ‘hold' rating. The targets range from $30 to $50, and the recent ratings by Needham, Benchmark, and Morgan Stanley imply a 10.91% upside for the stock.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/IONQ/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="384" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12075115/ANR-IONQ-1024x384.png" alt="" class="wp-image-947500" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12075115/ANR-IONQ-1024x384.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12075115/ANR-IONQ-300x113.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12075115/ANR-IONQ-768x288.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12075115/ANR-IONQ.png 1282w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Benzinga Edge Stock Rankings shows that IonQ had a stronger price trend over the short, medium, and long term. Its momentum ranking was solid; however, its value ranking was poor at the 3.20th percentile. The details of other metrics are <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">available here</a>.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="148" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12074600/IONQ-EDGE-1024x148.png" alt="" class="wp-image-947495" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12074600/IONQ-EDGE-1024x148.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12074600/IONQ-EDGE-300x43.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12074600/IONQ-EDGE-768x111.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12074600/IONQ-EDGE.png 1044w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were lower in premarket on Thursday. The SPY was down 0.51% at $598.30, while the QQQ declined 0.54% to $529.51, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/45899298/automotive-and-apparel-companies-absorbed-tariff-costs-amid-better-than-expected-may-cpi-print-but-dont-expect-that-to-continue-says-expert">Automotive And Apparel Companies &#8216;Absorbed Tariff Costs&#8217; Amid Better Than Expected May CPI Print: &#8216;But Don&#8217;t Expect That To Continue,&#8217; Says Expert</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image Via Shutterstock

AMZN

IONQ

NVDA

Jensen Huang's Quantum Support Boosts IonQ's Growth Plans: Nvidia Partnership, Oxford Ionics Deal Lead Needham To Reiterate 'Buy'

Jefferies analyst Julien Dumoulin-Smith upgrades TransAlta (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TA#TSX">TA</a>) from Hold to Buy and raises the price target from C$12 to C$20.

TSX:TA

Jefferies Upgrades TransAlta to Buy, Raises Price Target to C$20

Press Releases

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Hyperfine and NVIDIA Collaborate to Revolutionize Neuroimaging with AI-Powered Innovation

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices

Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025

Hyperfine, Inc. Reports First Quarter 2025 Financial Results

Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference

Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System

Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality

Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI

HYPR

Aethlon Medical

Apyx Medical

HeartBeam

Envoy Medical, Inc. - Class A Common Stock

Envoy Medical

CytoSorbents

Daxor

electroCore

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

Comments

Hyperfine

Notizie

Ultime notizie per Hyperfine (NASDAQ:HYPR) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO